fda stops tirzepatide New Blockbuster Type 2 Medication Mounjaro Gets Approval FDA Shortage and Semaglutide &

It also stimulates insulin secretion which allows cells to take up glucose and inhibits glucagon secretion, which prevents more glucose from being released into the bloodstream

In the SURPASS J-mono sub-study [14], treatment with 5 mg tirzepatide for 52 weeks resulted in significant reductions in body fat mass (4.1 kg) and body fat percentage (from 29.2% to 24.6%)

It is also cost savings (you use less medication over time) and more data per dose level (you get 6 to 8 weeks of weight loss data instead of 4, making it easier to determine whether a dose is truly working or has plateaued)

Is semaglutide better than dulaglutide

Metformin: Which Is Better

That can make GLP-1 agonists like Wegovy a better choice if your primary goal is weight management